Alesta - healthylife7.com

Browsing: Alesta

BioMarin to Acquire Alesta Therapeutics for Up to $490 Million

By healthylife7August 18, 20260

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has agreed to acquire Alesta Therapeutics in a deal worth up to $490 million, adding a clinical-stage oral therapy for hypophosphatasia to its rare disease pipeline and expanding its investment in skeletal conditions

What's Hot

Wynn wraps up annual Family Month to promote staff well-being and family connection

Bill Rasmussen, sports TV visionary and founder of ESPN, dies at 93

These 2 Fitness Tests Take Less Than a Minute and Can Reveal How Well You’re Aging

Browsing: Alesta

BioMarin to Acquire Alesta Therapeutics for Up to $490 Million

Wynn wraps up annual Family Month to promote staff well-being and family connection

Bill Rasmussen, sports TV visionary and founder of ESPN, dies at 93

These 2 Fitness Tests Take Less Than a Minute and Can Reveal How Well You’re Aging

The foods that help your brain stay sharp

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Wynn wraps up annual Family Month to promote staff well-being and family connection

Bill Rasmussen, sports TV visionary and founder of ESPN, dies at 93

These 2 Fitness Tests Take Less Than a Minute and Can Reveal How Well You’re Aging

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Browsing: Alesta